Conference
Basal biomarkers Nestin and INPP4b accurately identify intrinsic breast cancer subtype and predict benefit from anthracycline vs. non-anthracycline based treatment in the CCTG MA. 5 phase III randomized clinical trial
Authors
Asleh K; Gao DD; Tu D; Shepherd L; Levine MN; Pritchard K; Nielsen T
Volume
31
Pagination
pp. 46-46
Publisher
ELSEVIER SCIENCE INC
Publication Date
March 1, 2018
Name of conference
107th Annual Meeting of the United-States-and-Canadian-Academy-of-Pathology (USCAP) for Stowell-Orbison/Surgical Pathology
Conference place
CANADA, Vancouver
Conference start date
March 17, 2018
Conference end date
March 23, 2018
Conference proceedings
MODERN PATHOLOGY
ISSN
0893-3952